Skip to content

Role of Individualized Homoeopathic Medicine in LM Potency For The Management Of Hypothyroidism

The Role Of Individualized Homoeopathic Medicine In LM Potency For The Management Of Hypothyroidism - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/09/073664
Enrollment
40
Registered
2024-09-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E02- Subclinical iodine-deficiency hypothyroidism

Interventions

Intervention1: Individualized Homoeopathic Medicine: Individualized Homoeopathic Medicine will be prescribe to individuals having Hypothyroidism. Individualized homeopathic medicine will be prescribed

Sponsors

Dr. Pooja Sojitra
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pre-diagnosed cases and diagnosed cases of Hypothyroidism having increase TSH level. 2.Any sex, religion or socioeconomic status Willing to participate in the study and provide informed consent.

Exclusion criteria

Exclusion criteria: 1.Patients with secondary or tertiary hypothyroidism or those with hypothyroidism secondary to a surgical or radiation-induced cause. 2.Patient taking any other mode of treatment. 3.Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
1. Individualized Homoeopathic Medicines in LM Potencies are effective in Hypothyroidism. 2. Reduction of symptoms of Hypothyroidism. 3. Will measure the change in thyroid-stimulating hormone (TSH) levels. Timepoint: 15 days

Secondary

MeasureTime frame
To assess treatment outcome in cases of Hypothyroidism using Zulewski’s clinical score.Timepoint: 3 month

Countries

India

Contacts

Public ContactDr Jigna Nimavat

Jawaharlal Nehru Homoeopathic Medical College

jigna.nimavat87119@paruluniversity.ac.in7046705677

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026